Literature DB >> 29911401

Combining tumor size and diffusion-weighted imaging to diagnose normal-sized metastatic pelvic lymph nodes in cervical cancers.

Jiacheng Song1, Qiming Hu2, Junwen Huang1, Zhanlong Ma1, Ting Chen1.   

Abstract

BACKGROUND: Detecting normal-sized metastatic pelvic lymph nodes (LNs) in cervical cancers, although difficult, is of vital importance.
PURPOSE: To investigate the value of diffusion-weighted-imaging (DWI), tumor size, and LN shape in predicting metastases in normal-sized pelvic LNs in cervical cancers.
MATERIAL AND METHODS: Pathology confirmed cervical cancer patients with complete magnetic resonance imaging (MRI) were documented from 2011 to 2016. A total of 121 cervical cancer patients showed small pelvic LNs (<5 mm) and 92 showed normal-sized (5-10 mm) pelvic LNs (39 patients with 55 nodes that were histologically metastatic, 53 patients with 71 nodes that were histologically benign). Preoperative clinical and MRI variables were analyzed and compared between the metastatic and benign groups.
RESULTS: LN apparent diffusion coefficient (ADC) values and short-to-long axis ratios were not significantly different between metastatic and benign normal-sized LNs (0.98 ± 0.15 × 10-3 vs. 1.00 ± 0.18 × 10-3 mm2/s, P = 0.45; 0.65 ± 0.16 vs. 0.64 ± 0.16, P = 0.60, respectively). Tumor ADC value of the metastatic LNs was significantly lower than the benign LNs (0.98 ± 0.12 × 10-3 vs. 1.07 ± 0.21 × 10-3 mm2/s, P = 0.01). Tumor size (height) was significantly higher in the metastatic LN group (27.59 ± 9.18 mm vs. 21.36 ± 10.40 mm, P < 0.00). Spiculated border rate was higher in the metastatic LN group (9 [16.4%] vs. 3 [4.2%], P = 0.03). Tumor (height) combined with tumor ADC value showed the highest area under the curve of 0.702 ( P < 0.00) in detecting metastatic pelvic nodes, with a sensitivity of 59.1% and specificity of 78.8%.
CONCLUSIONS: Tumor DWI combined with tumor height were superior to LN DWI and shape in predicting the metastatic state of normal-sized pelvic LNs in cervical cancer patients.

Entities:  

Keywords:  Diffusion-weighted magnetic resonance imaging; cervical cancer; lymph node; metastasis

Mesh:

Year:  2018        PMID: 29911401     DOI: 10.1177/0284185118780903

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

Authors:  Njål Lura; Kari S Wagner-Larsen; David Forsse; Jone Trovik; Mari K Halle; Bjørn I Bertelsen; Øyvind Salvesen; Kathrine Woie; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Insights Imaging       Date:  2022-06-17

2.  Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.

Authors:  Chen Xu; Siyao Du; Siyu Zhang; Bo Wang; Chengyan Dong; Hongzan Sun
Journal:  Eur Radiol       Date:  2020-02-10       Impact factor: 5.315

3.  The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review.

Authors:  Benedetta Gui; Luca Russo; Laura Minordi; Maura Miccò; Salvatore Persiani; Giacomo Avesani; Vittoria Rufini; Valentina Fuoco; Rosa Autorino; Gabriella Ferrandina; Giovanni Scambia; Riccardo Manfredi
Journal:  Pol J Radiol       Date:  2022-08-10

4.  Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer.

Authors:  Mengting Wang; Min Ma; Liju Yang; Chengtong Liang
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

5.  Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.

Authors:  Fangjie He; Shuiling Zu; Xia Chen; Jianping Liu; Ying Yi; Haijun Yang; Fuqiang Wang; Songhua Yuan
Journal:  Cancer Med       Date:  2021-07-18       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.